Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Vivibene AS
AS
Active
Org 922412693
Bekkestuveien 21C, 1357
Bekkestua
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2019 · 7 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Retail sale of pharmaceutical products
/
Vivibene AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 2M
2M
2021
2022: 3M (+50% vs 2021)
3M
+50%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 4M (+33% vs 2023)
4M
+33%
2024
2025: 4M (0% vs 2024)
4M
0%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
3 773
3 817
3 442
2 612
1 613
Staff expenses
−6
−19
−24
−12
−3
EBITDA
−191
−64
58
522
156
Depreciation & amort.
−23
−23
−23
−23
−20
EBIT
−214
−87
35
499
136
Net financials
−20
−31
−25
−27
−8
Profit before tax
−234
−118
10
472
129
Tax
−0
−2
2
102
−0
Net profit
−234
−116
8
370
129
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
876
1 143
1 208
1 259
729
Equity
668
902
1 018
1 010
640
Long-term debt
0
0
2
0
0
Short-term debt
208
241
188
249
89
Total debt
208
241
190
249
89
Financial ratios
5-year trend
EBITDA margin
−5,1 %
This company
15,8 %
Market median
This company
Market median
132% below market
2021
2025
Equity ratio
76,2 %
This company
38,2 %
Market median
This company
Market median
99% above market
2021
2025
Return on equity
−35,0 %
This company
18,4 %
Market median
This company
Market median
290% below market
2021
2025
Net profit margin
−6,2 %
This company
8,1 %
Market median
This company
Market median
177% below market
2021
2025
Asset turnover
4,31×
This company
1,12×
Market median
This company
Market median
285% above market
2021
2025
Debt / equity
0,31×
This company
0,62×
Market median
This company
Market median
50% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Vivibene AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
